Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.
Cichocki F, Zhang B, Wu CY, Chiu E, Day A, O'Connor RS, Yackoubov D, Simantov R, McKenna DH, Cao Q, Defor TE, Janakiram M, Wangen R, Cayci Z, Snyder N, Kumar A, Grzywacz B, Hwang J, Geffen Y, Miller JS, Maakaron J, Bachanova V. Cichocki F, et al. Among authors: janakiram m. Sci Transl Med. 2023 Jul 19;15(705):eade3341. doi: 10.1126/scitranslmed.ade3341. Epub 2023 Jul 19. Sci Transl Med. 2023. PMID: 37467318 Free PMC article.
Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma.
Merino AM, Mehta RS, Luo X, Kim H, De For T, Janakiram M, Cooley S, Wangen R, Cichocki F, Weisdorf DJ, Miller JS, Bachanova V. Merino AM, et al. Among authors: janakiram m. Transplant Cell Ther. 2021 Apr;27(4):310.e1-310.e6. doi: 10.1016/j.jtct.2020.10.023. Epub 2020 Dec 17. Transplant Cell Ther. 2021. PMID: 33836870 Free PMC article.
Chimeric antigen receptor T-cell therapy for HIV-associated diffuse large B-cell lymphoma: case report and management recommendations.
Allred J, Bharucha K, Özütemiz C, He F, Janakiram M, Maakaron J, Carrier C, Grzywacz B, Bachanova V. Allred J, et al. Among authors: janakiram m. Bone Marrow Transplant. 2021 Mar;56(3):679-682. doi: 10.1038/s41409-020-01018-7. Epub 2020 Aug 6. Bone Marrow Transplant. 2021. PMID: 32764581 Free PMC article. No abstract available.
Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
Savani M, Gencturk M, Shanley R, Cayci Z, Wilke C, Warlick ED, He F, Janakiram M, Weisdorf DJ, Brunstein CG, Bachanova V. Savani M, et al. Among authors: janakiram m. Biol Blood Marrow Transplant. 2020 Feb;26(2):272-277. doi: 10.1016/j.bbmt.2019.10.013. Epub 2019 Oct 24. Biol Blood Marrow Transplant. 2020. PMID: 31669174 Free article.
Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.
El Jurdi N, Fair C, Rogosheske J, Shanley R, Arora M, Bachanova V, Betts B, He F, Holtan S, Janakiram M, Maakaron J, Rashidi A, Warlick E, Weisdorf D, Brunstein CG. El Jurdi N, et al. Among authors: janakiram m. Transplant Cell Ther. 2021 Feb;27(2):179.e1-179.e4. doi: 10.1016/j.jtct.2020.11.005. Epub 2020 Dec 13. Transplant Cell Ther. 2021. PMID: 33830033 Free article.
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group.
El Jurdi N, Elhusseini H, Beckman J, DeFor TE, Okoev G, Rogosheske J, Lazaryan A, Weiler K, Bachanova V, Betts BC, Blazar BR, Brunstein CG, He F, Holtan SG, Janakiram M, Gangaraju R, Maakaron J, MacMillan ML, Rashidi A, Warlick ED, Bhatia S, Vercellotti G, Weisdorf DJ, Arora M. El Jurdi N, et al. Among authors: janakiram m. Blood Cancer J. 2021 May 18;11(5):96. doi: 10.1038/s41408-021-00488-2. Blood Cancer J. 2021. PMID: 34006823 Free PMC article.
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
El Jurdi N, Rogosheske J, DeFor T, Bejanyan N, Arora M, Bachanova V, Betts B, He F, Holtan S, Janakiram M, Larson S, Maakaron J, Rashidi A, Warlick E, Wagner JE, Young JH, Weisdorf D, Brunstein CG. El Jurdi N, et al. Among authors: janakiram m. Transplant Cell Ther. 2021 Jan;27(1):84.e1-84.e5. doi: 10.1016/j.bbmt.2020.10.008. Epub 2020 Oct 11. Transplant Cell Ther. 2021. PMID: 33053448 Free PMC article.
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Bachanova V, Bishop MR, Dahi P, Dholaria B, Grupp SA, Hayes-Lattin B, Janakiram M, Maziarz RT, McGuirk JP, Nastoupil LJ, Oluwole OO, Perales MA, Porter DL, Riedell PA; CAR T-cell Consortium. Bachanova V, et al. Among authors: janakiram m. Biol Blood Marrow Transplant. 2020 Jul;26(7):1239-1246. doi: 10.1016/j.bbmt.2020.04.008. Epub 2020 Apr 14. Biol Blood Marrow Transplant. 2020. PMID: 32298807 Free PMC article. Review.
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
Epperla N, Zhao Q, Chowdhury SM, Shea L, Moyo TK, Reddy N, Sheets J, Weiner DM, Geethakumari PR, Kandarpa M, Bruno XJ, Thomas C, Churnetski MC, Hsu A, Zurbriggen L, Tan C, Lindsey K, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova E, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G. Epperla N, et al. Among authors: janakiram m. J Hematol Oncol. 2022 Jul 16;15(1):96. doi: 10.1186/s13045-022-01316-1. J Hematol Oncol. 2022. PMID: 35842643 Free PMC article.
83 results